Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy‐induced stress-Reference-Cited by-同舟云学术

Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy‐induced stress

Published:2014-03-17 Issue:4 Volume:105 Page:445-454
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Zhang Jun‐gang¹²,Hong De‐fei¹,Zhang Cheng‐wu¹,Sun Xiao‐dong¹,Wang Zhi‐fei¹,Shi Ying³,Liu Jun‐wei¹,Shen Guo‐liang¹,Zhang Yuan‐biao¹,Cheng Jian¹,Wang Chun‐you²,Zhao Gang²

Affiliation:

1. Hepatobiliary and Pancreatic Surgery Zhejiang Provincial People's Hospital HangzhouChina

2. Pancreatic Disease Institute Union Hospital Tongji Medical College Huazhong University of Science and Technology WuhanChina

3. Obstetrics and Gynecology Zhejiang Provincial People's Hospital Hangzhou China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12364

Reference46 articles.

1. Pancreatic cancer biology and genetics

2. Pancreatic cancer

3. Cancer Statistics, 2006

4. Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells

5. Transcription factors and drug resistance

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation and inhibition of sirtuins: From bench to bedside;Medicinal Research Reviews;2024-08-31

2. SIRT7 knockdown promotes gemcitabine sensitivity of pancreatic cancer cell via upregulation of GLUT3 expression;Cancer Letters;2024-08

3. Emerging therapeutic strategy for mitigating cancer progression through inhibition of sirtuin-1 and epithelial-mesenchymal transition;Pathology - Research and Practice;2023-11

4. The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer;Molecular and Cellular Biochemistry;2023-07-05

5. Evaluating the iron chelator function of sirtinol in non-small cell lung cancer;Frontiers in Oncology;2023-06-15